About Us
At Karyoon Consulting Services, we help researchers and biotech startups bring their ideas to life. Whether you’re developing a new therapy, planning your first clinical trial, or navigating complex regulations, we’re here to guide you every step of the way.
With years of experience across both academia and industry, our team understands the challenges of turning scientific discoveries into approved treatments. We’ve worked in areas like immunology, oncology, respiratory and infectious diseases, antibiotic resistance, and gene therapy, so we speak your language.
Need help with ethics submissions? First-in-human trials? Clinical trial management or business strategy? We simplify the process so you can focus on what matters most: your science.
At Karyoon, we combine deep scientific knowledge with real-world experience to help you move faster, smarter, and with confidence, from early research to regulatory approval.
With deep expertise in regulatory compliance, trial operations, and global strategy, we take care of the details, so you can stay focused on the science.
Leadership Team
Hiep Nguyen
Managing Director & Founder
PhD in Molecular Biology
The University of Newcastle
Dr. Hiep brings over 10 years of experience across academia and the biotech industry, with deep expertise in immunology, microbiology, oncology, respiratory diseases, and oncolytic immunotherapies. She has led numerous research projects from concept to completion, including study design, sample collection, data analysis, and publication , with a strong focus on Good Clinical Practice (GCP) and clinical trial management.
Her regulatory knowledge spans the development of Standard Operating Procedures (SOPs), implementation of Quality Management Systems (QMS), and the standardization of testing protocols to ensure compliance across all stages of research.
Currently serving as a Senior Grants Officer at the University of Newcastle, Dr. Hiep oversees the full lifecycle of funded research and clinical trials, from contract negotiation and trial setup to compliance and closeout. She specializes in trials involving unapproved therapies, managing Clinical Trial Notification (CTN) and Clinical Trial Application (CTA) submissions to the TGA, as well as trial registrations and clinical trial research agreements.
With a strong command of TGA, FDA, and EMA regulations, GxP standards, and commercialization pathways, Dr. Hiep is a trusted advisor in clinical development and regulatory strategy.
Vu Thi Ngoc Bich
Director & Consultant
PhD in Molecular Biology
Radboud University Medical Center (Radboudumc), Netherlands
Dr. Bich brings deep expertise in clinical trial management, with a proven track record of leading projects from early discovery through to clinical execution. Her background combines strong scientific knowledge with hands-on experience in both academic and regulatory environments.
With a PhD in molecular microbiology and a focus on bacterial infections, antibiotic resistance, the microbiome, and the One Health approach, Dr. Bich offers valuable technical insight into complex clinical and regulatory challenges. Her work has spanned multiple therapeutic areas, with a particular emphasis on antimicrobial resistance (AMR) and infectious diseases.
As a Postdoctoral Researcher at the Oxford University Clinical Research Unit (OUCRU) in Vietnam, Dr. Bich has successfully led and contributed to numerous high-impact studies. She is passionate about advancing global health and works closely with local and international partners to prevent, detect, and respond rapidly to infectious disease threats and AMR challenges.
Szun Tay
Principal Consultant
PhD in Immunology
Imperial College London
Dr. Szun is a senior research scientist with over 20 years of experience in immunology and gene therapy, with a focus on T cell programming in the liver and solid tumors. She holds a PhD in Immunology from Imperial College London and has held postdoctoral positions at the University of Cambridge, the University of Sydney, and UNSW. Her early career included clinical research roles at the Royal Free Hospital in London, Addenbrooke’s Hospital in Cambridge, and an internship at GlaxoSmithKline.
Dr. Szun is passionate about translational research and advancing equitable, evidence-based therapies. Her technical expertise spans advanced immunoassays, cell therapy development, viral vector engineering (AAV, lentivirus, retrovirus), and in vivo efficacy studies.
Most recently, she served as a Senior Research Associate at ImmVirX, where she led research in cancer immunotherapy. She is currently based at the Garvan Institute of Medical Research, where she is developing accessible CAR T cell and NK cell therapies for advanced cancers.
Ready To Take The Next Step?
Ready to move forward? Book a free 30-minute strategy session and let’s explore how we can support your next clinical milestone.